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has potential beneﬁ t as a basic educational tool for students and health professionals 
interested in exploring these analytical approaches. 
CONCEPTUAL PAPERS & RESEARCH ON METHODS – Modeling Methods
PMC4
CHOOSING THE RIGHT DISTRIBUTION WHEN PERFORMING 
PROBABILISTIC SENSITIVITY ANALYSIS: RELATIVE RISKS AND THE 
TRIANGULAR DISTRIBUTION A SIMULATION STUDY
Kim H1, Gurrin L2, Liew D1
1The University of Melbourne, Fitzroy, Victoria, Australia; 2University of Melbourne, Carlton, 
Victoria, Australia
OBJECTIVES: In economics the triangular distribution is often used when limited 
information is available for different parameters. This is also the case in health eco-
nomic modeling when performing probabilistic sensitivity analysis (PSA). In PSA, 
distributions are assigned to input parameters in order to assess the uncertainty in the 
model. One of the main criticisms of PSA is that the distributions can be chosen 
arbitrarily. Analysts can thereby manipulate the choice of distributions to bias the 
results. This study investigates the usage of the triangular distribution for describing 
the uncertainty of relative risks (RR) compared to the lognormal distribution and 
empirical distribution RR generated through simulations. METHODS: Ten thousand 
simulations of the triangular distribution, the log normal distribution and relative risks 
constructed from two binomial distributions were performed. Descriptive statistics 
and graphical plots were constructed. RESULTS: The triangular distribution does not 
have the support of the full positive real axis and as such extreme values, such as very 
small and very large numbers, have a zero probability of being measured. However, 
values around the mode are prone to be drawn with a higher probability compared 
to both the exact values and the log normal distribution. The lognormal distribution 
tends to overestimate the RR compared to the empirical distribution. CONCLU-
SIONS: This study shows that the triangular distribution is a poor choice for charac-
terizing the uncertainty of RR. The overestimation of the RR can introduce bias, for 
instance, if used for responder rates or death rates. The lognormal distribution appears 
to be a better approximation, but if the actual number of events and total number of 
exposed are available, the empirical simulation is of course preferred. 
CONCEPTUAL PAPERS & RESEARCH ON METHODS – Patient-Reported 
Outcomes Studies
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OBJECTIVES: This research aimed to estimate utility tariffs for Malaysia using Time 
Trade Off (TTO) and Visual Analogue Scale (VAS) valuations of the EQ-5D descrip-
tive system. METHODS: TTO and VAS valuations were obtained from face to face 
surveys in 2004 and 2005 of 152 adult patients, their care-givers and health profes-
sionals at six government hospitals in Malaysia. The survey closely followed the 
methodology of EQ5D health states by Shaw et al. Forty-ﬁ ve EQ-5D health states 
were valued, divided into ﬁ ve sets of 15 health states each. Each respondent was asked 
to value one set of 15 health states. Each respondent performed a ranking, the VAS 
and TTO valuations. TTO allowed for scoring health states as worse than death. 
Linear additive regression models were performed. Dependent variables were the 
rescaled VAS and TTO values. Independent variables were two dummy variables for 
each of the ﬁ ve EQ-5D dimensions and two pre-deﬁ ned interaction terms, N3 and 
D1. RESULTS: A total of 152 respondents were obtained with mean age 41 years and 
self-assessed VAS of 82. Respondents reported TTO valuations to be difﬁ cult or more 
difﬁ cult (16%) than VAS valuation (8%). A greater number of VAS valuations had 
no inconsistencies compared to TTO valuations (63% and 17% respectively). All N3 
and D1 models were statistically signiﬁ cant. Goodness-of-ﬁ t was better in VAS models 
(adjusted R2 0.755 and 0.757) than N3 models (adjusted R2 0.424 and 0.412). All 
the independent variables in the models were statistically signiﬁ cant and theoretically 
consistent with expected signs and magnitude, with level 3 coefﬁ cients larger than 
level 2 coefﬁ cients for the same health dimension. CONCLUSIONS: Both N3 and D1 
model speciﬁ cations were applicable to Malaysian EQ-5D health valuations. VAS 
valuations appear to be better than TTO. 
PMC7
TRANSLATING ITEM BANKS: BENEFITS AND CHALLENGES
Arnold BJ1, Lent L1, Correia H2, Cella D2
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With the emergence of electronic data collection and efforts to reduce respondent 
burden, the use of item banks to measure health related constructs—especially within 
federally funded (NIH) research—has become more mainstream. Following the use 
and acceptance of Computer Adaptive Testing (CAT) in educational testing, item 
banks in health status assessment allow for better measurement of a construct across 
the measurement continuum. As with standard static questionnaires used in outcomes 
assessment, there is a need for multilingual translations of item banks in order to 
establish and compare item hierarchies across varying languages and cultures. Transla-
tion and validation of items contained in item banks presents interesting scientiﬁ c 
opportunities for cross-cultural health assessment, but there are also attendant chal-
lenges to be addressed. This presentation will give a brief overview of the beneﬁ ts of 
computer adaptive testing while outlining the most salient issues related to the evalu-
ation of item difﬁ culty and hierarchy. It will also highlight differences and unique 
challenges brought about by translating item banks. Topics such as maintaining 
consistent terminology, recall period and verb tense will be addressed and examples 
from our experience will be provided. Appropriate translation methodology, copyright 
issues and the role of both qualitative and quantitative data in the process will also 
be discussed as well as brief examples of how items that are similar linguistically and 
conceptually may have different item parameters in different languages. 
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PREDICTING THE SF-6D PREFERENCE-BASED INDEX SCORE USING 
THE SF-8 HEALTH SURVEY
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OBJECTIVES: This study aimed to develop a function to predict the SF-6D index 
score from SF-8 scores. METHODS: This study was a secondary analysis of data 
collected in a population health survey in Singapore in which respondents (n = 7529) 
completed both the SF-36 and the SF-8 questionnaires. Four multiple linear regression 
models with different speciﬁ cations were compared for their performance in predicting 
SF-6D scores calculated using responses to SF-8 items. RESULTS: The model in which 
responses to all SF-8 items were coded into dummy variables achieved the best predic-
tion outcomes. The model explained 62% (other models: 56% to 62%) of the variance 
in the SF-6D index score with the mean absolute error being 0.056 (other models: 
0.056 to 0.06100) and root mean square error being 0.076 (other models: 0.077 to 
0.083). The absolute error between predicted and observed SF-6D scores was less than 
0.1 and 0.05 among 84% and 59% of the respondents, respectively; this results for 
other modes were 77% to 84% and 51% to 56%. CONCLUSIONS: It is possible to 
generate a utility-based index score from the SF-8. The function developed in this 
study should be further tested in other populations. 
CONCEPTUAL PAPERS & RESEARCH ON METHODS – Statistical Methods
PMC10
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While the value of information (VoI) methods have been developed for model based 
cost-effectiveness analyses (CEA), there is a gap in applying such methods to CEAs 
conducted alongside clinical trials. In the present it is shown that by treating the 
probability distribution of net beneﬁ ts within each trial arm as a random quantity, 
calculations for the Expected Value of Sample Information (EVSI) for model-based 
CEAs can be extended to the setting of a trial-based CEA where individual net beneﬁ ts 
from subjects are available. In this case EVSI calculates the expected return of invest-
ment from conducting a future trial with the similar design as a function of its sample 
size. Based on such analogy, a nonparametric method for EVSI calculation based on 
two-level bootstrap is introduced. At the ﬁ rst level, a Bayesian bootstrap (Rubin, 1981) 
from the vector of individual-level net beneﬁ ts within each arm of the trial is per-
formed. The empirical distribution of such a bootstrap sample amounts to a random 
draw from the ‘posterior distribution of the distribution’ of net beneﬁ ts given the 
observed data. A second bootstrap from this sample then models the distribution of 
net beneﬁ ts in the future study. The data of the future and current trials will be 
combined to identify the maximum net beneﬁ t and the cycle is repeated over several 
iterations. We also extend this framework to address parametric analysis (e.g., net 
beneﬁ t regression), missing values, and incorporation of external evidence. We use 
data from a randomized clinical trial of combination therapy in COPD as an applica-
tion. Since the two-level bootstrap directly generates samples of the individual-level 
data for the future trial, it allows modeling realistic scenarios (e.g., missing values, 
complex statistical analysis). This, combined with the nonparametric nature of the 
method, should provide a robust framework for VoI analysis for trial-based CEAs. 
MENTAL HEALTH – Clinical Outcomes Studies
PMH1
METABOLIC SYNDROME AND SECOND GENERATION 
ANTIPSYCHOTICS UTILIZATION—IMPACT OF PSYCHIATRIC 
COMORBIDITY AND POLYPHARMACY
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OBJECTIVES: Current studies examining metabolic effects associated with second 
generation antipsychotics (SGAs) do not consider the impact of psychiatric comorbidi-
